Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • pharma company

    Tag: pharma company

    You Searched For "pharma company"
    Former BDM, others arrested for stealing data from pharma firm

    Former BDM, others arrested for stealing data from pharma firm

    Farhat Nasim15 Jan 2020 10:30 AM IST
    Investigations revealed that the prime accused, who was a Business Development Manager in the pharma company was fired on the charge of malpractices.
    DoP rejects Geltec plea to review price of Ibuprofen Capsule fixed by NPPA

    DoP rejects Geltec plea to review price of Ibuprofen Capsule fixed by NPPA

    Farhat Nasim13 Jan 2020 3:44 PM IST
    New Delhi: In a major setback to drugmaker Geltec Private Limited, the Department of Pharmaceuticals (DoP) has junked its review petition against the...
    More drugmakers including Gilead, Biogen, BMS to hike US prices for 50 drugs

    More drugmakers including Gilead, Biogen, BMS to hike US prices for 50 drugs

    Medical Dialogues Bureau2 Jan 2020 2:48 PM IST
    New Delhi: Drugmakers including Bristol-Myers Squibb Co (BMY.N), Gilead Sciences Inc (GILD.O), and Biogen Inc (BIIB.O) hiked U.S. list prices on more...
    FIRST: Mylan, Micro Labs get USFDA nod for generic version of blood thinner Eliquis

    FIRST: Mylan, Micro Labs get USFDA nod for generic version of blood thinner Eliquis

    Medical Dialogues Bureau24 Dec 2019 9:45 AM IST
    Sales of Eliquis, which Bristol-Myers co-developed with Pfizer, rose 22% to $1.93 billion and made up about 30% of the Bristol-Myers' total revenues...
    Zydus Cadila unveils affordable anti-diabetic drug Vildagliptin under brands Vinglyn, Vinglyn M

    Zydus Cadila unveils affordable anti-diabetic drug Vildagliptin under brands Vinglyn, Vinglyn M

    Medical Dialogues Bureau12 Dec 2019 11:53 AM IST
    Ahmedabad: With the Novartis Blockbuster Vildagliptin going off patent, Zydus Cadila has taken made its move towards affordable diabetes care in India...
    Pfizer Abrilada, biosimilar to Humira gets USFDA nod for multiple inflammatory conditions

    Pfizer Abrilada, biosimilar to Humira gets USFDA nod for multiple inflammatory conditions

    Farhat Nasim20 Nov 2019 12:44 PM IST
    New Delhi: Pfizer Inc. recently announced the United States (U.S.) Food and Drug Administration (USFDA) has approved ABRILADA (adalimumab-afzb), as a...
    Mylan, Pfizer say Mylan-Upjohn combined entity to be known as Viatris

    Mylan, Pfizer say Mylan-Upjohn combined entity to be known as Viatris

    Medical Dialogues Bureau16 Nov 2019 9:20 AM IST
    New Delhi: Mylan N.V. and Pfizer Inc. recently announced that the name of the new company to be formed by the planned combination of Mylan and Upjohn,...
    Natco Pharma Q2 profit declines to Rs 118 crore due to drop in oseltamivir product sales in US

    Natco Pharma Q2 profit declines to Rs 118 crore due to drop in oseltamivir product sales in US

    Medical Dialogues Bureau13 Nov 2019 9:33 AM IST
    "The decline in revenues and profits compared to the same period last year is primarily due to the anticipated drop in oseltamivir product sales in...
    RedHill Biopharma Talicia wins USFDA nod for treating bacterial infection

    RedHill Biopharma Talicia wins USFDA nod for treating bacterial infection

    Medical Dialogues Bureau11 Nov 2019 9:15 AM IST
    The drug, Talicia, is an oral capsule comprising two antibiotics, amoxicillin and rifabutin, as well as omeprazole, a common treatment for...
    Abbott discovers new strain of HIV, keeping global health community step ahead of virus

    Abbott discovers new strain of HIV, keeping global health community step ahead of virus

    Medical Dialogues Bureau10 Nov 2019 9:00 AM IST
    New Delhi: Abbott announced recently that a team of its scientists identified a new subtype of the human immunodeficiency virus (HIV), called HIV-1...
    New USFDA warning letters show Glenmark, Lupin, Cadila Healthcare in trouble

    New USFDA warning letters show Glenmark, Lupin, Cadila Healthcare in trouble

    Medical Dialogues Bureau7 Nov 2019 4:20 PM IST
    Cadila Healthcare Ltd., Glenmark Pharmaceuticals Ltd. and Lupin Ltd. are the latest local medicine makers to be reprimanded by the US Food and Drug...
    Sun Pharma signs licensing pact with AstraZeneca to introduce Novel Oncology products in China

    Sun Pharma signs licensing pact with AstraZeneca to introduce Novel Oncology products in China

    Medical Dialogues Bureau6 Nov 2019 1:26 PM IST
    Mumbai-Indian drugmaker giant Sun Pharma announced today about entering into an agreement with AstraZeneca to enter the Chinese market with novel...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok